Authorisation holders

GlaxoSmithKline AG: Swissmedic authorisations

GlaxoSmithKline AG is registered with Swissmedic as the authorisation holder of 91 medicines. The most common category is Synthetic medicines. The list below shows every authorisation with its number and dispensing category.

  • Synthetic medicines64
  • Vaccines21
  • Biotechnological medicines6

All medicines from GlaxoSmithKline AG

Adartrel 0Authorisation number 56907 · ATC N04BC04BAnoro Ellipta 55 mcg/22 mcgAuthorisation number 63152 · ATC R03AL03BAREXVYAuthorisation number 69310 · ATC J07BX05BArnuity Ellipta 90 mcgAuthorisation number 65707 · ATC R03BA09BAugmentin 1 g (875/125)Authorisation number 53692 · ATC J01CR02AAugmentin 625 mg (500/125)Authorisation number 45674 · ATC J01CR02AAugmentin Duo 457 mg (400/57)Authorisation number 53974AAvamysAuthorisation number 57968 · ATC R01AD12BAvodartAuthorisation number 56106 · ATC G04CB02BAxotide 125Authorisation number 54306 · ATC R03BA05BAxotide Diskus 100Authorisation number 53390 · ATC R03BA05BBactrobanAuthorisation number 47667 · ATC D06AX09BBactrobanAuthorisation number 54316 · ATC D06AX09BBactroban NasalAuthorisation number 52361 · ATC R01AX06ABenlystaAuthorisation number 66585 · ATC L04AG04BBenlysta 120 mgAuthorisation number 61532 · ATC L04AG04ABetnovateAuthorisation number 30968 · ATC D07AC01BBetnovateAuthorisation number 30969 · ATC D07AC01BBetnovateAuthorisation number 30970 · ATC D07AC01BBetnovate Scalp ApplicationAuthorisation number 33311 · ATC D07AC01BBexseroAuthorisation number 65730 · ATC J07AH09BBlenrep 70 mgAuthorisation number 69910 · ATC L01FX15ABoostrixAuthorisation number 637 · ATC J07AJ52BBoostrix PolioAuthorisation number 681 · ATC J07CA02BCutivateAuthorisation number 52381 · ATC D07AC17BDaraprimAuthorisation number 20964 · ATC P01BD01BDermovateAuthorisation number 39905 · ATC D07AD01BDermovateAuthorisation number 39906 · ATC D07AD01BDermovate Scalp ApplicationAuthorisation number 41823 · ATC D07AD01BDeroxatAuthorisation number 51188 · ATC N06AB05BDuac AkneAuthorisation number 58494 · ATC D10AF51BDuodartAuthorisation number 60095 · ATC G04CA52BEmovateAuthorisation number 43142 · ATC D07AB01BEngerix-B 10Authorisation number 551 · ATC J07BC01BEngerix-B 20Authorisation number 534 · ATC J07BC01BFluarixAuthorisation number 70042 · ATC J07BB02BFluarix Tetra 15 µg / 0.5 mlAuthorisation number 62961 · ATC J07BB02BHavrix 1440Authorisation number 558 · ATC J07BC02BHavrix 720Authorisation number 599 · ATC J07BC02BHiberixAuthorisation number 603 · ATC J07AG01BImigran 10 mgAuthorisation number 53708 · ATC N02CC01BImigran 50 mgAuthorisation number 51685 · ATC N02CC01BImigran 6 mg/0.5 mlAuthorisation number 51684 · ATC N02CC01BImigran T 50 mgAuthorisation number 56411 · ATC N02CC01BIncruse ElliptaAuthorisation number 65091 · ATC R03BB07BInfanrix DTPa-IPVAuthorisation number 638 · ATC J07CA02BInfanrix DTPa-IPV+HibAuthorisation number 619 · ATC J07CA06BInfanrix hexaAuthorisation number 640 · ATC J07CA09BJemperli 500 mg/10 mlAuthorisation number 68023 · ATC L01FF07ALamictal 5 mgAuthorisation number 52853 · ATC N03AX09BMalaroneAuthorisation number 54150 · ATC P01BB51AMenveoAuthorisation number 62502 · ATC J07AH08BNaramigAuthorisation number 54272 · ATC N02CC02BNucala 100 mg/mLAuthorisation number 67350 · ATC R03DX09BNucala 100 mg/mLAuthorisation number 67351 · ATC R03DX09BOmjjara 100 mgAuthorisation number 69428 · ATC L01EJ04APriorixAuthorisation number 615 · ATC J07BD52BPriorix-TetraAuthorisation number 58158 · ATC J07BD54BRelenza 5 mgAuthorisation number 55108 · ATC J05AH01BRelvar Ellipta 92/22 mcgAuthorisation number 62969 · ATC R03AK10BRequip 0Authorisation number 53841 · ATC N04BC04BRequip-Modutab 2 mgAuthorisation number 57740 · ATC N04BC04BRotarixAuthorisation number 60150 · ATC J07BH01BSeretide 50Authorisation number 55552 · ATC R03AK06BSeretide Diskus 100Authorisation number 54975 · ATC R03AK06BSereventAuthorisation number 57169 · ATC R03AC12BSerevent DiskusAuthorisation number 53021 · ATC R03AC12BShingrixAuthorisation number 67987 · ATC J07BK03BToctino 10 mgAuthorisation number 58711 · ATC D11AH04ATrelegy ElliptaAuthorisation number 66808 · ATC R03AL08BTwinrix 720/20Authorisation number 592 · ATC J07BC20BValtrex 500 mgAuthorisation number 53116 · ATC J05AB11AVarilrixAuthorisation number 585 · ATC J07BK01BVentolinAuthorisation number 37262 · ATC R03CC02BVentolinAuthorisation number 54320 · ATC R03AC02BVentolin 0.5 mg/mlAuthorisation number 44397 · ATC R03AC02BVentolin 5 mg/mlAuthorisation number 37397 · ATC R03AC02BVentolin DiskusAuthorisation number 53898 · ATC R03AC02BVolibris 5 mgAuthorisation number 58654 · ATC C02KX02BWellbutrin XR 150 mgAuthorisation number 57803 · ATC N06AX12BWellvoneAuthorisation number 53563 · ATC P01AX06AZeffixAuthorisation number 54868 · ATC J05AF05AZeffixAuthorisation number 54869 · ATC J05AF05AZejula 100 mgAuthorisation number 68652 · ATC L01XK02AZentelAuthorisation number 49748 · ATC P02CA03BZentelAuthorisation number 49749 · ATC P02CA03BZoviraxAuthorisation number 45705 · ATC D06BB03BZoviraxAuthorisation number 47431 · ATC J05AB01AZovirax 200 mgAuthorisation number 45343 · ATC J05AB01AZovirax i.v.Authorisation number 44772 · ATC J05AB01AZybanAuthorisation number 55263 · ATC N06AX12A

Frequently asked questions

How many medicines does GlaxoSmithKline AG have authorised in Switzerland?

91 medicines, data as of 01 September 2026. The count covers human medicine authorisations in the Swissmedic export, not individual pack sizes.

What does an authorisation holder do?

The authorisation holder applies for the authorisation, maintains it, owns the product information, reports adverse reactions to Swissmedic and keeps the product available. Under Art. 10 TPA it must have a registered office in Switzerland.

Can an authorisation be transferred?

Yes. The transfer of an authorisation to a new holder is notified to Swissmedic and carries a fee. Product information, packaging material and pharmacovigilance responsibility transfer with it.

Dispute this entry

We are happy to correct entries. Send us a note through the form, we check it against the current Swissmedic export and update the record.

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com

Sources

Swissmedic data as of 01 September 2026

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com